Home
About
Editor’s Corner
Contribute
Contact Us

Thought Leadership
Healthcare C-Suite Movements
Digital in Pharma
Events
Solutions & Pricing
Partner

Hot topics

Personalizing the Selling – What Pharma Needs to Understand about Customers and their Experiences

"Customer Experience," abbreviated "CX," refers to all the perceptions...

American Tariffs and The Rise of the Corporate Superpower

From Nation-States to Corporate Titans: How Innovation is Redrawing...

What Exactly Does Going Digital Mean?

Going digital is not about Social media or Omni channels. Is it about asking simple questions. Best Buy is one of the largest electronic good retailers in USA. Few years ago Best Buy was threatened by what is now known as Showrooming effect. Basically customers would walk into its showrooms get benefitted by the advice of the salesperson, decide on the model and then go online to buy the product on Amazon because of low prices. Despite having one the best footfalls in the decade Best Buy recorded reduced profits. Although it did try to Price match Amazon they knew it was not a long-term solution because of its cost structure (Physical showrooms, salespeople etc). They couldn’t block the customers from checking price of product on Amazon. Future looked uncertain, everyone thought game over for Best Buy which was the case with many other retailing giants. No amount of investing new technology would have helped Best Buy . Best Buy relearned how to make profits. Best Buy proposed to the manufacturers that they compensate Best Buy for exclusive showcasing of manufacturers new products. Manufacturers also could launch specific brand kiosks within Best Buy showroom for a fee. This new model which had zero investment for Best Buy dramatically increased its profitability. Is this a ground breaking innovation? Of course NO. This has already been practiced in other industries but for the first time tried in Electronic good Retail. Best Buy realized apart from consumers it created lot of value for manufacturers therefore it captured the value lost from consumers from manufacturers. What is my business? What is my business ecosystem? How do I currently make money? How changing one thing impacts my ecosystem? What are the options available?

The Killer Nexus – What Really Ails Indian Healthcare?

For Every Bottle Of Killer Cough Syrup Doctor Prescribed,...

Careers in Medical Device Companies

Key Insights Thermo Fisher Scientific leads the industry with $42.88 billion...

Contact Us
Terms of Service
Privacy Statement

Facebook

Youtube

Healthcare Trends

The Architects of Immunity: How a Handful of Nations Are Shaping the Future of Global Health

The Paradox of Protection In the time it takes to...

Levamisole Withdrawn in EU: Will India’s Regulator Follow?

On February 13, 2026, the Pharmacovigilance Risk Assessment Committee...

Uniform Code for Pharmaceutical Marketing Practices: 2011 and Now

In September 2011, MedicinMan published a UCPMP Special Issue...

Aflibercept: When Originators Stop Fighting and Start Licensing

When Regeneron Pharmaceuticals and Bayer AG signed a licensing...

India’s Pharma Renaissance: Private Equity at the Helm

Indian pharmaceuticals have long been known as the “pharmacy...

Marketing

The Architects of Immunity: How a Handful of Nations Are Shaping the Future of Global Health

The Paradox of Protection In the time it takes to...

Levamisole Withdrawn in EU: Will India’s Regulator Follow?

On February 13, 2026, the Pharmacovigilance Risk Assessment Committee...

Uniform Code for Pharmaceutical Marketing Practices: 2011 and Now

In September 2011, MedicinMan published a UCPMP Special Issue...

Aflibercept: When Originators Stop Fighting and Start Licensing

When Regeneron Pharmaceuticals and Bayer AG signed a licensing...

India’s Pharma Renaissance: Private Equity at the Helm

Indian pharmaceuticals have long been known as the “pharmacy...

Policies/Sales

The Architects of Immunity: How a Handful of Nations Are Shaping the Future of Global Health

The Paradox of Protection In the time it takes to...

Levamisole Withdrawn in EU: Will India’s Regulator Follow?

On February 13, 2026, the Pharmacovigilance Risk Assessment Committee...

Uniform Code for Pharmaceutical Marketing Practices: 2011 and Now

In September 2011, MedicinMan published a UCPMP Special Issue...

Aflibercept: When Originators Stop Fighting and Start Licensing

When Regeneron Pharmaceuticals and Bayer AG signed a licensing...

India’s Pharma Renaissance: Private Equity at the Helm

Indian pharmaceuticals have long been known as the “pharmacy...

Strategy

The Architects of Immunity: How a Handful of Nations Are Shaping the Future of Global Health

The Paradox of Protection In the time it takes to...

Levamisole Withdrawn in EU: Will India’s Regulator Follow?

On February 13, 2026, the Pharmacovigilance Risk Assessment Committee...

Uniform Code for Pharmaceutical Marketing Practices: 2011 and Now

In September 2011, MedicinMan published a UCPMP Special Issue...

Aflibercept: When Originators Stop Fighting and Start Licensing

When Regeneron Pharmaceuticals and Bayer AG signed a licensing...

India’s Pharma Renaissance: Private Equity at the Helm

Indian pharmaceuticals have long been known as the “pharmacy...

Hot topics

Eli Lilly’s Acquisition of Adverum Signals Focus on Gene Therapies to Redefine Eye Care

Eli Lilly’s planned acquisition of Adverum Biotechnologies is a...

What my Sabziwali taught me about the Internet, Mobile Health & Smartphones

It’s very common for a pharma professional having neighbors, friends and relatives to engage in conversation over medicines. One such conversation – a pleasant surprise – which intrigued me to dig deep into internet dynamics was one with the local roadside Sabziwali.